Genetic Testing Can Improve Cannabis Breeding, Compliance, and Crop Selection

Genetic testing is giving cannabis breeders and hemp producers a way to identify important traits before plants mature—and, in some cases, before they flower. The technology can help researchers connect a plant’s DNA with its cannabinoid profile, determine sex at the seedling stage, and reduce the risk of developing crops that exceed legal THC limits.

The approach is especially valuable because cannabis varieties can differ substantially in their concentrations of cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD), as well as in their terpene profiles. These chemical differences contribute to a plant’s aroma and may influence its effects. However, the names and commercial descriptions attached to cannabis varieties do not always provide a reliable guide to their genetic or chemical characteristics. Genetic analysis can help clarify those relationships, although it does not replace laboratory testing of finished products.

Connecting genes with cannabis chemistry

A 2019 study published in Plant Physiology examined nine commercial cannabis strains using transcriptomic and metabolomic data. Researchers led by Jordan Zager and Bernd Markus Lange of Washington State University, in collaboration with Anthony Smith of EVIO Labs, analyzed gene expression in glandular trichomes and measured cannabinoids and terpenes in flower buds.

Glandular trichomes are specialized structures on female cannabis flowers that produce and store resin. That resin contains cannabinoids and terpenes, which are synthesized through related but distinct biochemical systems that draw on shared precursor molecules. By combining RNA sequencing with chemical measurements, the researchers identified gene networks associated with differences in cannabinoid and terpenoid accumulation among the strains.

The work did not establish that a particular genetic profile inevitably produces a specific consumer experience. Nor did it prove the often-invoked “entourage effect”—the idea that cannabinoids and terpenes work together to produce distinctive effects. Instead, it provided a framework for investigating how genetic regulation contributes to the chemical diversity found in cannabis.

RNA sequencing was useful because it measured patterns of gene activity without requiring researchers to select every gene target in advance. Gas chromatography and liquid chromatography supplied complementary chemical data: gas chromatography is commonly used for volatile compounds such as terpenes, while liquid chromatography is well suited to measuring cannabinoids.

Testing cannabinoid type and sex in young plants

For breeders, some of the most useful genetic tests target traits that are difficult or expensive to determine early in a plant’s development. Cannabis plants may be genetically male, female, or monoecious, yet young plants can look alike until flowering begins. In many production systems, identifying sex early helps breeders manage pollination and avoid investing resources in unwanted plants.

Researchers at Cornell University developed and validated high-throughput PACE assays for plant sex and cannabinoid chemotype. PACE, or PCR Allele Competitive Extension, is a fluorescence-based method for detecting specific genetic variants. The Cornell assays distinguished male plants from female and monoecious plants and identified genetic categories associated with THC-dominant, CBD-dominant, and intermediate THC-to-CBD chemotypes.

The cannabinoid chemotype is largely controlled by a major genetic locus involving the enzymes responsible for producing THC and CBD. In practical terms, plants can carry two THC-associated versions, two CBD-associated versions, or one of each. The researchers found that populations marketed as CBD hemp were not always genetically or chemically uniform, and some plants classified as hemp accumulated THC above the then-applicable U.S. legal threshold of 0.3% by dry weight.

These findings matter because a crop’s tendency to exceed the THC limit is not necessarily evidence of poor growing conditions. In the Cornell field trials, genetic differences were more strongly associated with cannabinoid outcomes than the differences between growing sites. Screening seedlings can therefore help breeders select plants with a lower risk of producing noncompliant crops.

What genetic testing can—and cannot—do

For breeding programs, molecular markers can shorten the selection process. Instead of waiting for plants to mature and then measuring their flowers, breeders can screen young plants for sex or cannabinoid type and focus greenhouse and field space on the most promising individuals. The same information can help manage breeding populations, preserve desirable traits, and reduce the cost of phenotyping.

Genetic testing may also support regulatory compliance by identifying plants that carry genetic variants associated with THC production. But DNA results are not a substitute for chemical analysis. Environmental conditions, plant maturity, tissue sampled, cultivation practices, and laboratory methods can all affect measured cannabinoid concentrations. Producers still need validated chemical testing to determine the composition of harvested material and finished products.

For consumers, the immediate value is more limited. A genetic test may help authenticate or characterize plant material, but it cannot by itself verify every claim made on a product label, predict an individual’s response, or determine the quality and safety of a retail product. Those questions require chemical testing, manufacturing controls, and accurate labeling.

Remaining barriers

Adoption has practical limitations. Molecular assays require reliable sample handling, specialized equipment such as a fluorescence plate reader or qPCR system, trained personnel, and quality-control procedures that reduce the risk of sample mix-ups. Testing every plant in a large commercial field may also remain too expensive, even when the cost per sample is lower than waiting for mature-plant analysis.

Regulatory requirements add another complication. Cannabis and hemp testing rules differ across jurisdictions and can change over time, so producers must use methods accepted by the relevant authority. Genetic screening is most useful when it is integrated with, rather than substituted for, established chemical and compliance testing.

As cannabis genome resources, sequencing methods, and analytical tools improve, genetic testing should become increasingly useful for targeted breeding and crop management. Its strongest near-term applications are early selection of plant sex and cannabinoid type, investigation of the genes behind chemical traits, and development of more consistent cultivars. The technology can make production more efficient, but reliable cannabis characterization will continue to depend on combining genetics with careful cultivation records and direct chemical analysis.

Additional research and breeding resources are available through Washington State University’s cannabis biosynthesis program and Cornell Hemp’s molecular-marker resources.